All News #Library
Biotech
Enara Bio Licenses Dark Antigen to Boehringer
08 Jan 2026 //
GLOBENEWSWIRE
Enara Bio’s DARKFOX Discovery Propels ENA101
04 Nov 2025 //
GLOBENEWSWIRE
Enara Bio Unveils DARKFOX, Cancer-Specific Antigen At SITC 2025
06 Oct 2025 //
PHARMAWEB
Enara Bio Unveils DARKFOX, Cancer-Specific Antigen At SITC 2025
03 Oct 2025 //
GLOBENEWSWIRE
Enara Bio Expands Leadership, Accelerates T-Cell Programs
01 May 2025 //
GLOBENEWSWIRE
Enara Bio Gets $32.5M Series B For Dark Antigens® TCR Pipeline
03 Oct 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support